Biotoxtech Co Stock Market Capitalization
| 086040 Stock | KRW 5,600 50.00 0.88% |
Biotoxtech Co fundamentals help investors to digest information that contributes to Biotoxtech's financial success or failures. It also enables traders to predict the movement of Biotoxtech Stock. The fundamental analysis module provides a way to measure Biotoxtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotoxtech stock.
Biotoxtech |
Biotoxtech Co Company Market Capitalization Analysis
Biotoxtech's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Biotoxtech Market Capitalization | 115.73 B |
Most of Biotoxtech's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotoxtech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Biotoxtech Co is about 115.73 B. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The market capitalization for all Republic of Korea stocks is notably lower than that of the firm.
Biotoxtech Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotoxtech's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotoxtech could also be used in its relative valuation, which is a method of valuing Biotoxtech by comparing valuation metrics of similar companies.Biotoxtech is currently under evaluation in market capitalization category among related companies.
Biotoxtech Fundamentals
| Return On Equity | 13.27 | |||
| Return On Asset | 0.0343 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 156.1 B | |||
| Shares Outstanding | 14.56 M | |||
| Shares Owned By Insiders | 26.95 % | |||
| Shares Owned By Institutions | 0.68 % | |||
| Price To Earning | 47.60 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 34.09 B | |||
| Gross Profit | 6.4 B | |||
| EBITDA | 5.67 B | |||
| Net Income | 6.98 B | |||
| Cash And Equivalents | 18.59 B | |||
| Cash Per Share | 803.72 X | |||
| Total Debt | 2.01 B | |||
| Debt To Equity | 47.30 % | |||
| Current Ratio | 0.71 X | |||
| Book Value Per Share | 1,604 X | |||
| Cash Flow From Operations | 4.35 B | |||
| Target Price | 15000.0 | |||
| Beta | 0.84 | |||
| Market Capitalization | 115.73 B | |||
| Total Asset | 90.74 B | |||
| Retained Earnings | (4.82 B) | |||
| Working Capital | (4.75 B) | |||
| Current Asset | 13.46 B | |||
| Current Liabilities | 18.21 B | |||
| Z Score | 34.2 | |||
| Net Asset | 90.74 B |
About Biotoxtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotoxtech Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotoxtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotoxtech Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotoxtech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotoxtech's short interest history, or implied volatility extrapolated from Biotoxtech options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotoxtech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Biotoxtech information on this page should be used as a complementary analysis to other Biotoxtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Biotoxtech Stock analysis
When running Biotoxtech's price analysis, check to measure Biotoxtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotoxtech is operating at the current time. Most of Biotoxtech's value examination focuses on studying past and present price action to predict the probability of Biotoxtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotoxtech's price. Additionally, you may evaluate how the addition of Biotoxtech to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |